Fourth Meeting on Access to Medicines Under Universal Health Coverage in the Asia Pacific Region. 26–27 September 2017, Seoul, Republic of Korea
(2017; 90 pages)


The meeting was organized by the Organization for Economic Co-operation and Development (OECD) Korea Policy Centre, OECD, World Health Organization Western Pacific Region (WPRO), and World Health Organization Collaborating Centre for Health Systems and Financing.

Participants from a total of sixteen Asia-Pacific member countries (Australia, Bangladesh, Cambodia, China, Indonesia, Lao PDR, Malaysia, Maldives, Mongolia, Philippines, Republic of Korea, Japan, Singapore, Sri Lanka, Thailand, and Viet Nam) and experts from Ewha Womans University (Republic of Korea), Health Insurance Review and Assessment Services (HIRA, Republic of Korea), National Health Insurance Service (NHIS, Republic of Korea ), University of Tokyo (Japan), University of Newcastle (Australia), University of South Australia (Australia), and Fudan University (China) were convened for the meeting.

Participants and experts discussed high cost medicines, pharmaceutical policies in countries and new pricing strategies, future activities and agenda, and the role of the network; topics presented and discussed were as follows:

  • Regional update on access to medicines in the Western Pacific
  • Strategic purchasing initiative in South East Asia
  • Value in pharmaceutical pricing: cross-country analysis
  • Malaysia plan for better access to hepatitis C treatment
  • Pricing and reimbursement policy of similar biotherapeutic products in Korea
  • Access to orphan drugs in Thailand
  • Medicines pricing and HTA in China
  • Medicines price regulation in Sri Lanka
  • Discussion on medicines price regulation in the Philippines
  • Utilisation data for evaluating access and price setting in selected countries
  • Risk-sharing through Managed Entry Agreements
  • Overview of pharmaceutical pricing methods
  • Medicines Pricing regulation in Japan
  • The role of HTA in pricing and reimbursement of pharmaceuticals
  • On how to improve access to medicines under UHC: a framework for analysis
Documents similaires
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019